Use of once-daily raltegravir-based HAART in HIV-infected injection drug users.

Autor: Tossonian, HK1, Raffa, JD2, Alenezi, O1, Anderson, K1, Jassemi, S1, Wight, K1, DeVlaming, S3, Conway, B1
Zdroj: Journal of the International AIDS Society. Nov2010 Supplement S3, Vol. 13, pP36-P36. 1p.
Databáze: Academic Search Ultimate